Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
97,693,461
-
Total 13F shares
-
2,999,021
-
Share change
-
+51,027
-
Total reported value
-
$15,474,095
-
Put/Call ratio
-
410%
-
Price per share
-
$5.16
-
Number of holders
-
34
-
Value change
-
+$204,505
-
Number of buys
-
13
-
Number of sells
-
8
Institutional Holders of Rani Therapeutics Holdings, Inc. - Common Stock (RANI) as of Q1 2023
As of 31 Mar 2023,
Rani Therapeutics Holdings, Inc. - Common Stock (RANI) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,999,021 shares.
The largest 10 holders included
VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, UNITED SERVICES AUTOMOBILE ASSOCIATION, Alphabet Inc., Alpha Square Group S, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., and LASRY MARC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.